Secondary prevention of coronary heart disease in patients with extracoronary atherosclerosis: A need for accuracy of low density lipoprotein determination

Angiology

Volumn 47, Issue 3, 1996, Pages 241-246

  Sentí, Mariano ^a   Pedro Botet, Juan ^a,b   Rubiés Prat, Juan ^a   Vidal Barraquer, Francesc ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL DEL MAR   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CEREBROVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; DISEASE CLASSIFICATION; HUMAN; LABORATORY TEST; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PERIPHERAL VASCULAR DISEASE; RELIABILITY;

EID: 0029969580     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331979604700304     Document Type: Article

References (26)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, National Cholesterol Education Program: Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evolution, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). JAMA 269:3015-3023, 1993.
2. Vitale E, Zuliani G, Bicego L, et al: Lipoprotein abnormalities in patients with extracoronary arteriosclerosis. Atherosclerosis 81:95-102, 1990.
3. Pedro-Botet J, Sentí M, Nogués X, et al: Lipoprotein abnormalities in normolipidemic patients with extracoronary atherosclerosis: Seeking new lipoprotein risk profiles. Nutr Metab Cardiovasc Dis 4:64-69, 1994.
4. Criqui MH, Browner D, Fronek A, et al: Peripheral arterial disease in large vessels is epidemiologically distinct from small vessel disease. Am J Epidemiol 129:1110-1119, 1989.
5. Senti M, Nogués X, Pedro-Botet J, et al: Lipoprotein profile in men with peripheral vascular disease. Role of intermediate density lipoproteins and apoprotein E phenotypes. Circulation 85:30-36, 1992.
6. Pedro-Botet J, Sentí M, Nogués X, et al: Lipoprotein and apolipoprotein profile in men with ischemic stroke. Role of lipoprotein(a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphism. Stroke 23:1556-1562, 1992.
7. Tyrrell J, Cooke T, Reilly M, et al: Lipoprotein -Lp(a)-and peripheral vascular disease. J Intern Med 232:349-352, 1992.
8. Pedro-Botet J, Senti M, Auguet T, et al: Apolipoprotein(a) genetic polymorphism and serum lipoprotein(a) concentration in patients with peripheral vascular disease. Atherosclerosis 104:87-94, 1993.
9. Bachorik PS: Collection of blood samples for lipoprotein analysis. Clin Chem 28:1375-1378, 1982.
10. Terpstra AHM, Woodward CJH, Sánchez-Muñíz FJ: Improved techniques for the separation of serum lipoproteins by density gradient ultracentrifugation. Visualization by prestaining and rapid separation of serum lipoproteins from small volumes of serum. Ann Biochem 111:149-157, 1981.
11. Fontanals-Ferrer N, Serrat-Serrat J, Sorribas-Vivas A, et al: Quick method of determining lipoproteins, including those of intermediate density, in serum. Clin Chem 34:1753-1757, 1988.
12. Lopes-Virella MF, Stone P, Ellis S, et al: Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem 23:882-884, 1977.
13. Warnick GR, Cheung MC, Albers JJ: Comparison of current methods for high-density lipoprotein cholesterol quantitation. Clin Chem 25:596-604, 1979.
14. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502, 1972.
15. Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1:307-310, 1986.
16. Godfrey K: Simple linear regression in medical research. In: Medical Uses of Statistics, ed. by Bailar III JC, Mosteller F. Waltham, MA: NEJM Books, 1986, pp 170-205.
17. Kramer MS, Feinstein AR: Clinical biostatistics. LIV. The biostatistics of concordance. Clin Pharmacol Ther 29:111-123, 1981.
18. Rhoads GG, Dahlen G, Berg K, et al: Lp(a) lipoprotein as a risk factor for myocardial infarction. JAMA 256:2540-2544, 1986.
19. Steiner G, Schwartz L, Shumak S, et al: The association of increased levels of intermediate-density lipoproteins with smoking and with coronary artery disease. Circulation 75:124-130, 1987.
20. Austin MA, King MC, Vranizan KM, et al: Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation 82:495-506, 1990.
21. Nestel PJ: Is serum triglyceride an independent predictor of coronary artery disease? Pract Cardiol 13:96-101, 1987.
22. Austin MA: Plasma triglyceride as a risk factor for coronary heart disease: The epidemiologic evidence and beyond. Am J Epidemiol 129:249-259, 1989.
23. Havel RJ: Role of triglyceride-rich lipoproteins in progression of atherosclerosis. Circulation 81:694-696, 1990.
24. Criqui MH, Heiss G, Cohn R, et al: Plasma triglyceride level and mortality from coronary heart disease. N Engl J Med 328:1220-1225, 1993.
25. Blankenhorn DH, Alaupovic P, Wickham E, et al: Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts. Circulation 81:470-476, 1990.
26. Rubiés-Prat J, Reverter JL, Sentí M, et al: Calculated low-density lipoprotein cholesterol should not be used for management of lipoprotein abnormalities in patients with diabetes mellitus. Diabetes Care 16:1081-1086, 1993.